Even though the number of cases examined is small, as the authors stated, this result supports their hypothesis that COX-2 contributes to superficial BC recurrence, thus selective COX-2 inhibitors can be a candidate chemo preventive agents for reoccurrence. Here, PTGS2 is linked to breast cancer.